We are live on ! Find out more
TVRD

Tvardi Therapeutics
TVRD

56 hedge funds and large institutions have $104M invested in Tvardi Therapeutics in 2014 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

27% more capital invested

Capital invested by funds: $81.5M → $104M (+$22M)

18% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 11

0% more funds holding

Funds holding: 56 → 56 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

26% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 19

Holders
56
Holders Change
–
Holders Change %
0%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
13
Increased
14
Reduced
19
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$2.57M
2
California Public Employees Retirement System
California Public Employees Retirement System
California
+$1.19M
3
DM
Deerfield Management
New York
+$810K
4
OM
Opaleye Management
Massachusetts
+$716K
5
Citigroup
Citigroup
New York
+$485K

Top Sellers

Rank Fund Capital Flow
1
AAM
Aberdeen Asset Management
United Kingdom
-$7.46M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.15M
3
VAM
Visium Asset Management
New York
-$881K
4
OTPPB
Ontario Teachers' Pension Plan Board
Ontario, Canada
-$798K
5
MSA
Mason Street Advisors
Wisconsin
-$532K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
51
UBS Group
Switzerland
$5K +$4.51K +14 New
Barclays
52
Barclays
United Kingdom
$4K +$1.93K +6 +120%
Morgan Stanley
53
Morgan Stanley
New York
$2K -$43.8K -136 -96%
Wells Fargo
54
Wells Fargo
California
$2K – – –
Manulife (Manufacturers Life Insurance)
55
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$22 -$6.44K -20 -25%
AAM
56
Aberdeen Asset Management
United Kingdom
– -$7.46M -24,712 Closed
VAM
57
Visium Asset Management
New York
– -$881K -2,917 Closed
OTPPB
58
Ontario Teachers' Pension Plan Board
Ontario, Canada
– -$798K -2,642 Closed
MSA
59
Mason Street Advisors
Wisconsin
– -$532K -1,761 Closed
NMLIC
60
Northwestern Mutual Life Insurance Company
Wisconsin
– -$532K -1,761 Closed
GPP
61
Great Point Partners
Connecticut
– -$397K -1,314 Closed
CAM
62
ClariVest Asset Management
California
– -$287K -891 -100%
NI
63
Numeric Investors
Massachusetts
– -$255K -843 Closed
CS
64
Credit Suisse
Switzerland
– -$166K -552 Closed
ARTA
65
A.R.T. Advisors
New York
– -$136K -451 Closed
SO
66
STRS Ohio
Ohio
– -$43K -142 Closed
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
– -$998 -3 Closed
1 2
3

TVRD Hedge Fund Activity: Q4 2014 in Review

56 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Tvardi Therapeutics (TVRD) for Q4 2014, worth a combined $104M — up 27% from $81.5M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new TVRD positions and 11 closed out — a net gain of 2 holders — while 14 added to existing stakes and 19 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $2.57M. The largest seller was Aberdeen Asset Management, exiting entirely with an estimated $7.46M sold.

  • 56 institutional investors held Tvardi Therapeutics (TVRD) as of Q4 2014, unchanged from Q3 2014.
  • Funds reported $104M of Tvardi Therapeutics stock for Q4 2014, up 27% quarter-over-quarter.
  • 13 funds opened new Tvardi Therapeutics positions in Q4 2014 and 11 closed out, a net change of +2 holders.
  • The largest Tvardi Therapeutics buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $2.57M added.
  • The largest Tvardi Therapeutics seller in Q4 2014 was Aberdeen Asset Management, an estimated $7.46M sold.

Based on aggregated 13F filings for Q4 2014.